GTC Biotherapeutics
GTC Biotherapeutics Reports First Quarter 2009 Financial Results
Published in Healthcare Finance, Tax and Law Weekly, May 27th, 2009
GTC Biotherapeutics, Inc. ("GTC", Nasdaq: GTCB) reported that total net loss for the first quarter of 2009 was $10.4 million, or $0.10 per share, compared with $8.2 million, or $0.10 per share, for the first quarter of 2008. Revenues were approximately $0.2 million for the first quarter of 2009 compared to $3.5 million for the first quarter of 2008. Revenues were reduced from the first quarter of 2008 primarily due to the completion of activities in supporting service contracts for external programs. During the first quarter of 2009, we received approximately $4.7 million of milestone payments, including $4 million from Lundbeck Inc. on the ATrynŽ (Antithrombin [Recombinant]) program,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
More Articles from Healthcare Finance, Tax and Law Weekly
- A.M. Best Co.
BestWeek: Florida Lawmakers Shift Thinking, Pass Bills to Face the Risk - Access to Medical Imaging Coalition
AMIC Unveils RightScanRightTime.org - AdvaMed
Patients Call for Continued FDA Preemption Authority - Affinion Security Center
Affinion Security Center Survey Finds Identity Theft Impacts Women More Than Men - Aging
AAHSA Joins Sixty Aging and Disability Groups to Fight for Long-Term Services and Supports in Health Care Reform - Ahern Fleury
Business Law Firm Ahern Fleury Opens in Birmingham, Michigan to Help Safeguard Corporate Assets: Retention, Protection and Collection - More from this issue of Healthcare Finance, Tax and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
